One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1093/annonc/mdz248.052
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2019 |
 License type: publisher-specific-oa |
Affiliation: Chris O’Brien Lifehouse, Memorial Sloan Kettering Cancer Center, Peter MacCallum Cancer Centre, Institut Gustave Roussy, Amgen (United States), City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, Duke University, Sidney Kimmel Comprehensive Cancer Center, Yale Cancer Center895TiP - A phase I study of AMG 160, a half-life extended bispecific T cell engager (HLE BiTE) immuno-oncology therapy targeting PSMA, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
